Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial
- 227 Downloads
Background. Patients with reactive airways are at risk for adenosine-induced bronchocon-striction, mediated via A2B and/or A3 adenosine receptors.
Methods and Results. To examine the effects of regadenoson, a selective adenosine A2A receptor agonist, on airway resistance, we conducted a randomized, double-blind, placebo-controlled crossover trial in asthmatic patients with a positive adenosine monophosphate challenge test. The mean ratio of the forced expiratory volume in 1 second (FEV1) at each tested time point relative to the baseline FEV1 was significantly higher after treatment with regadenoson compared with placebo from 10 to 60 minutes after treatment. One patient had a substantial but asymptomatic FEV1 reduction (−36.2%) after regadenoson that reversed spontaneously. The most common adverse events with regadenoson were tachycardia (66%), dizziness (53%), headache (45%), and dyspnea (34%). The mean heart rate significantly increased with regadenoson (maximum of +10.4 beats/min) versus placebo.
Conclusions. In this pilot safety study of 48 patients with mild or moderate asthma who had bronchial reactivity to adenosine monophosphate, regadenoson was safe and well tolerated.
Key WordsReactive airways spirometry pulmonary function test stress test adenosine receptor
Unable to display preview. Download preview PDF.
- 3.Adenoscan (adenosine injection) [full prescribing information]. Deerfield (IL): Fujisawa Healthcare; 2004.Google Scholar
- 8.Cerqueira M, Nguyen N, Staehr P, et al. Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging: Integrated ADVANCE-MPI trial results. J Am Coll Cardiol 2008 (in press).Google Scholar
- 11.ADVAIR (fluticasone propionate and salmeterol) [full prescribing information]. Research Triangle Park (NC): GlaxoSmithKline; 2006.Google Scholar
- 14.Global strategy for asthma management and prevention. Global Initiative for Asthma Executive and Science Committees; 2006 Available from: URL: http://www.ginasthma.org.Google Scholar
- 17.National Asthma Education and Prevention Program clinical practice guidelines. Guidelines for the diagnosis and management of asthma. NIH publication 97-4051. Washington, DC: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute; 1997.Google Scholar